Aspire Biopharma (ASBP) Holdings announced a strategic initiative to rapidly increase the production capacity of its BUZZ BOMB single dose caffeine pre-workout supplement through a new manufacturing relationship with SupraNaturals. As part of this agreement, Aspire Biopharma announced an initial production order of two million servings of BUZZ BOMB pre-workout supplement, marking a significant milestone in the Company’s expansion efforts.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASBP: